| # | Drug | Count |
|---|---|---|
| 0 | ESCITALOPRAM | 5 |
| 1 | ESCITALOPRAM OXALATE | 4 |
| 2 | ESCITSLOPRAM | 3 |
| 3 | CABOZANTINIB | 2 |
| 4 | DUPILUMAB | 2 |
| 5 | ICOTROKINRA | 2 |
| 6 | ABALOPARATIDE | 1 |
| 7 | ADALIMUMAB | 1 |
| 8 | ARIPIPRAZOLE | 1 |
| 9 | ARIPIPRAZOLE ORAL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ICOTROKINRA | 2 | 0.0047 |
| 1 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 1 | 0.0008 |
| 2 | ERDAFITINIB | 1 | 0.0008 |
| 3 | PILOCARPINE HYDROCHLORIDE | 1 | 0.0004 |
| 4 | VIBEGRON | 1 | 0.0001 |
| 5 | FAM-TRASTUZUMAB DERUXTECAN-NXKI | 1 | 0.0001 |
| 6 | PANITUMUMAB | 1 | 0.0001 |
| 7 | CABOZANTINIB | 2 | 0.0000 |
| 8 | ESCITALOPRAM | 5 | 0.0000 |
| 9 | ABALOPARATIDE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Parathyroid Hormone-Related Peptide Analog [EPC] | 1 | 0.0000 |
| 1 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 2 | beta3-Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 3 | 5-alpha Reductase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |
| 7 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Interleukin-4 Receptor alpha Antagonist [EPC] | 2 | 0.0000 |
| 9 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |